Synthèse

The global herbal medicine market has experienced significant growth. The sector is expected to continue to expand at a CAGR of 10.9% between 2023 and 2030. Market growth is largely attributed to increased demand for immune-stimulating, chemical-free products, particularly following the outbreak of the COVID-19 pandemic.

Europe is the leading market for herbal medicines, thanks to significant R&D investment and market growth. In France, the phytotherapy market (including phytotherapy proper, aromatherapy and gemmotherapy) is also on the rise. The aromatherapy and gemmotherapy markets are estimated at 248 million euros and 3.4 million euros respectively.

The French market is largely driven by pharmacies and parapharmacies, which account for 74% of sales of phytotherapy products, while imported medicinal plants have jumped from 165 million euros in 2018 to 224 million euros in 2021, despite a negative trade balance.

Phytotherapy: an evolving market fuelled by natural health trends

The French herbal medicine market is enjoying remarkable growth, fueled by ever-increasing consumer interest in natural health products and plant-based therapies. In a country where almost two out of five people consider themselves ill-informed about natural treatments, and where one in three doubts their efficacy, the industry has managed to thrive, demonstrating the growing popularity and acceptance of alternative medicine. Phytotherapy, the practice of medicine using plants and plant extracts, has found itself at the forefront of this movement, responding to a public seeking less toxic, more organic health solutions.

The phytotherapy market in France is estimated at around 778 million euros in 2022, with growth of around 10% over the past five years. This market is expected to maintain strong growth momentum, with a projected annual growth rate of around 5% until 2025.

The French market features a wide variety of players, ranging from dietary supplement specialists such as Arkopharma, with sales of between €200 and €202 million, to healthcare groups and pharmaceutical companies, with giants such as Sanofi and Bayer recording sales in excess of 40 and 50 billion euros respectively.

This diversified market structure covers a wide range of consumer needs and preferences. Healthcare professionals play an essential role in the expansion of phytotherapy in France. A significant percentage of healthcare professionals believe in the benefits of phytotherapy and recommend it to patients, thus considerably influencing market dynamics. Consumers often rely on the recommendations of these reliable sources, underlining the market's development potential if more healthcare professionals become advocates of phytotherapy.

Despite its growth, herbal medicine faces challenges, the most important of which is the need to better inform the public about its efficacy and safe use. The COVID-19 pandemic has only reinforced consumers' search for chemical-free plant treatments to boost immunity. Organic and natural products are gaining ground, with areas devoted to organic farming having expanded considerably over the last decade, indicating a clear shift towards more sustainable and health-conscious consumer behavior.

Although mainly sold in pharmacies and parapharmacies, which account for the majority of market share, there has been a shift in distribution channels, with online sales and organic stores becoming increasingly important. This trend is further accelerated by consumers' changing purchasing habits and their search for convenience and healthier lifestyle choices.

In conclusion, the French herbal medicine market, part of a global industry that is set to more than double from $160 billion to over $360 billion by the end of the dethe phytotherapy market features a number of key players, each contributing to the sector's expansion and offering consumers a range of herbal medicinal options.

Understanding these key players allows us to delve deeper into market dynamics, illustrating specialties, offerings and their distinctive positioning.

  • Arkopharma is a specialist in dietary supplements, and stands out for its European leadership in the herbal medicine market. Their product range is extensive, offering a variety of dietary supplements, medicines and medical devices that focus on health through natural plant-based treatments. Arkopharma's presence is not limited to local territories, but extends to over 60 countries, demonstrating a global footprint in the field of herbal medicine.
  • Nutergia is renowned for its expertise in dietary supplements. Their formulations are centered on the concept of nutritional therapy, aimed at providing supplements that support the body's biochemical balance.
  • EE Pharma is another strong contender. Part of the Havea Group, it brings to the table a strong natural health portfolio, extending its reach with strategic products that address health and wellness needs.
  • Les 3 Chênes focuses on natural solutions and presents a blend of innovation and tradition in its dietary supplements. Their flexible approach meets a variety of health needs and aims to make natural health accessible to all.
  • Perrigo is a health group that extends its reach beyond herbal medicine, encompassing a wide range of over-the-counter wellness solutions. It understands the importance of accessibility and consumer trust in building a health-focused brand.
  • Urgo stands out in the healthcare sector for its specialized products that cover a wide range of health needs, combining innovation and user-friendliness in its offerings.
  • Pierre Fabre is a pharmaceutical company that integrates phytotherapy into a broader pharmaceutical context, bringing herbal products alongside conventional medicines and demonstrating a commitment to integrating natural options into healthcare.
  • Sanofi, already a giant in the pharmaceutical industry, has also moved into herbal medicine, recognizing the market potential and consumer inclination towards natural treatments.
  • Bayer, another pharmaceutical heavyweight, has expressed interest in the herbal medicine market, demonstrating its willingness to diversify its well-established product portfolio towards more natural health options.
  • Merck, also known for its pharmaceutical prowess, recognizes the complementary role of phytotherapy in general health and well-being.

Obtenez toutes informations essentielles
à la compréhension de ce marché

Détail du contenu

Informations

  • Nombre de pages : 30 pages
  • Format : Version digitale et PDF
  • Dernière mise à jour : 30/11/2023
Détail des mises à jour

Sommaire et extraits

1 Market overview

1.1 Definition and scope of study

Phytotherapy is medicine based on the use of plants or plant extracts and their natural properties, and comprises[FranceAgriMer] :

  • phytotherapy proper (infusions, decoctions, tinctures, medicinal plant extracts) ;
  • aromatherapy (essential oils) ;
  • gemmotherapy (extracts of buds, young shoots or other parts of medicinal plants).

Phytotherapy uses exclusively plant-based products obtained by extraction, generally diluted in alcohol or another solvent. Phytotherapy products may be available in various forms:

  • Whole or divided plants;
  • Various galenic forms (syrups, drops, tablets, capsules, sachets, ampoules).

Most phytotherapy products are marketed as dietary supplements or medicines . This study therefore focuses on medicinal plants, on which the entire industry is based, and on the various formats of phytotherapy products (mainly dietary supplements). This study excludes details on essential oils (aromatherapy), for which a dedicated study is available in our catalog.

Phytotherapy offers a number of major advantages: it is undoubtedly less toxic than drugs, and plant-based treatments accounted for less than 1% of reports of adverse reactions in 2015, all types of treatment combined.

As a result, the French herbal medicine market "proper" is booming: estimated at 778.4 million euros in 2022, it has grown by 10% since 2017, and should continue to grow at a CAGR of 5% until 2025[OpenHealth]. The aromatherapy and gemmotherapy markets are estimated at 248 million euros in 2022 and 3.4 million euros in 2021 respectively[FranceAgriMer].

Similarly, theglobal herbal medicine market is estimated at$160.2 billion in 2022 , and should continue to grow at aCAGR of 10.9% over the period 2023-2030, reaching $367.9 billion in 2030. europe largely dominates this market, with a high R&D budget particularly dedicated to it. [Market Research Future]

Indeed, in a global context of a return to natural, wellness, organic and healthier practices, phytotherapy is experiencing a certain craze. What's more, this growth has been driven by the advent of the Covid-19 epidemic, as people seek chemical-free plants to boost their immunity .

The challenge now is to better inform the public about natural treatments and their effectiveness, of which herbal medicine is one. Indeed, according to a study conducted by Ipsos in 2019, 38% of French people consider themselves ill-informed, and 32% doubt their effectiveness.

1.2 The French herbal medicine market is growing strongly

As we have already seen, the phytotherapy market comprises: phytotherapy proper (***),aromatherapy and gemmotherapy . The sales figures for these different segments are detailed below.

In ****, the phytotherapy market proper in pharmacies and parapharmacies (***) in France was estimated at *** million euros[***]. According to Arkopharma, pharmacies and parapharmacies accounted for **% of total sales ...

1.3 The global herbal medicine market

The global herbal medicine market was estimated at $***.* billion in **** , and is expected to continue growing at a CAGR of **.*% over the period ****-****, reaching $***.* billion in **** .

Global herbal medicine market size World, ****-****, in billions of dollars Source: ****

This growth is driven by the advent of the Covid-** epidemic . Indeed, ...

1.4 Foreign trade

Here, we look at imports and exports of dried aromatic and medicinal plants, followed by a breakdown of the main buyers and sellers, from and for France, of medicinal plants, aromatics, spices and aromatic seeds. Phytotherapy does not include spices and aromatic seeds, but these figures give us an idea of ...

2 Demand analysis

2.1 The perception of natural treatments and phytotherapy in France

The above data dates from **** and ****, but illustrates the trust the French have in phytotherapy, which is broadly the same in ****.

In ****, according to a survey conducted by Ipsos, **% of French people said they used natural treatments, of which **% used homeopathy, **% aromatherapy and **% phytotherapy as such. We can thus observe that ...

2.2 Consumer profile

In France, in ****, **% of consumers of natural treatments were women, and this proportion rose to **% when looking specifically at phytotherapy. Also, **% of natural treatment consumers had children. Finally, the consumer base was rather young, with **% aged under **.

However, this typical profile of natural treatment consumers has gradually become more masculine, and ...

2.3 The role of healthcare professionals

Present throughout the health pathway, and therefore in this case the purchasing pathway, healthcare professionals have a key role to play in the expansion of phytotherapy in France.

In ****, **% of healthcare professionals (***). Doctors were slightly less likely to believe in the virtues of alternative medicine, but **% were positive about the use ...

3 Market structure

3.1 Medicinal plant production in France

In the data compiled by France Agrimer, medicinal plants are included in a category of plants known as PPAM (***).

In ****, France will have **,*** hectares under PPAM cultivation, an increase of *% on ****, and **% on ****. The majority of this area will be occupied by perfume plants(***). France will have **,*** ha of medicinal plant ...

3.2 Distributing phytotherapy products

In France, the distribution of phytotherapy products is largely dominated by pharmacies and parapharmacies, which account for almost **% of market share, according to data supplied by Arkopharma (***). Supermarkets and hypermarkets account for *.*% of the market, online sales *.*% and organic and health food stores *.*%.

Distribution of phytotherapy products by channel France, ****, in Arkopharma ...

3.3 Arkopharma, market leader in phytotherapy, and acquisition by Dermapharm

Most of the major manufacturers of natural health products are present in pharmacies, but access remains difficult for many smaller players, not listed here, due to limited space in pharmacies. Laboratories such as Arkopharma, Sanofi, Bayer, Urgo, Mayoly Spindler and Biocodex, which are present in pharmacies, have crucial relationships with pharmacies ...

4 Offer analysis

4.1 Typology of phytotherapy products

Food supplements account for a large proportion of phytotherapy products sold in France. They can be marketed in a variety of galenic forms. The following data dates from ****, but gives a general idea of how herbal medicines are marketed.

In pharmacies, the vast majority (***).

Main formats of phytotherapy products (***) in pharmacies France, ...

4.2 Overview of market prices

The prices below are taken from an Arkopharma document detailing the selling prices of their products in pharmacies. They are therefore statements rather than averages. The focus here is on Arkogélules and Arkofluides, the two herbal products mainly presented in this document.

For Arkogélule products, the standard format is ...

4.3 Organic products on the rise

For phytotherapy products, organic sales remain relatively low in pharmacies, but are significantly higher in parapharmacy outlets, and especially in organic stores.

Over the last decade, the number of farms and areas devoted to organic PPAM has grown remarkably, with respective increases of +***% and +***% between **** and ****. In ****, the surface area devoted ...

5 Regulations

5.1 Medicinal plant sales in France

The sale of medicinal plants, and therefore the scope of practice of phytotherapy, is regulated by the Pharmacopoeia, which lists all recognized medicinal plants. Medicinal plants are considered to be substances with a therapeutic action, and as such, their sale is authorized only to pharmacists practicing in dispensaries. Private individuals may ...

5.2 Regulatory framework for plant-derived therapeutic products

A herbal medicine is a medicine whose active substance is exclusively one or more herbal substances or herbal preparations, or a combination of several herbal substances or herbal preparations. (***)[***]

Herbal medicinal products can be authorized in three ways:

Marketing authorization on the basis of a complete dossier (***); Marketing authorization on the ...

5.3 Regulatory framework for dietary supplements

In ****, European Directive ****/**/EC established a specific regulatory framework for food supplements. This framework provides a strict definition (***) and distinguishes between two groups: nutrients and other substances with a nutritional or physiological effect. It also sets out the procedures for labeling and marketing European supplements in Europe. Decree no. ****-*** transposes ...

Liste des graphiques

  • Les recommandations des médecines alternatives et complémentaires par les professionnels de santé
  • Vecteurs d'achat des produits de santé naturelle et des compléments alimentaires
  • "Pour chacune des médecines suivantes, croyez-vous à ses bienfaits pour la santé ?"
  • Chiffre d'affaires de la phytothérapie en pharmacie et parapharmacie
  • Taille du marché de l'aromathérapie en pharmacie, parapharmacie et magasin bio
Afficher Plus Masquer

Toutes nos études sont disponible en ligne et en PDF

Nous vous proposons de consulter un exemple de notre travail d'étude sur un autre marché !

Une question sur cette étude ?   (+33) 9 70 46 55 00

Dernières actualités

Chute des ventes de glyphosate chez Bayer - 25/07/2023
  • Le chiffre d'affaires prévu pour l'ensemble de l'exercice en cours est compris entre 48,5 et 49,5 milliards d'euros.
  • Bayer a acquis le groupe américain Monsanto en 2018 pour plus de 63 milliards d'euros.
  • Le titre de Bayer a perdu la moitié de sa valeur depuis 2018.
Chimie en pleine relance, Bayer étudie des scissions - 09/11/2023
  • Chiffre d'affaires de Bayer: Près de 50 milliards d'euros.
  • La date à laquelle Bayer prendra une décision concernant la scission de ses entités : mars 2024.
  • Perte de valeur du groupe Bayer en cinq ans : 40%.
  • Bayer est plombé par la chute des ventes de glyphosate
Ipsen se renforce sur le dynamique segment des maladies rares - 09/01/2023
  • Ipsen déboursera 1 milliard d’euros pour mettre la main sur la biotech américaine Albireo
  • Le marché des maladies rares avoisine les 150 milliards de dollars

Entreprises citées dans cette étude

Cette étude contient un panorama complet des entreprises du marché avec les derniers chiffres et actualités de chaque entreprise :

Arkopharma
Bayer
Ipsen
Santé Verte
Merck KGaA
Nutreov Physcience
PiLeJe
Fenioux Groupe
NaturHouse
Puressentiel France
Pranarôm (Inula Groupe)
Naturactive (Pierre Fabre)

Choisir cette étude c'est :

Accéder à plus de 35 heures de travail

Nos études sont le résultat de plus de 35 heures de recherches et d'analyses. Utiliser nos études vous permet de consacrer plus de temps et de valeur ajoutée à vos projets.

Profiter de 6 années d'expérience et de plus de 1500 études sectorielles déjà produites

Notre expertise nous permet de produire des études complètes dans tous les secteurs, y compris des marchés de niche ou naissants.

Notre savoir-faire et notre méthodologie nous permet de produire des études avec un rapport qualité-prix unique

Accéder à plusieurs milliers d'articles et données payantes

Businesscoot a accès à l'ensemble de la presse économique payante ainsi qu'à des bases de données exclusives pour réaliser ses études de marché (+ 30 000 articles et sources privées).

Afin d'enrichir nos études, nos analystes utilisent également des indicateurs web (semrush, trends…) pour identifier les tendances sur un marché et les stratégies des entreprises. (Consulter nos sources payantes)

Un accompagnement garanti après votre achat

Une équipe dédiée au service après-vente, pour vous garantir un niveau de satisfaction élevé. (+33) 9 70 46 55 00

Un format digital pensé pour nos utilisateurs

Vous accédez à un PDF mais aussi à une version digitale pensée pour nos clients. Cette version vous permet d’accéder aux sources, aux données au format Excel et aux graphiques. Le contenu de l'étude peut ainsi être facilement récupéré et adapté pour vos supports.

Nos offres :

the herbal medicine market | France

89 € HT
  • Quels sont les chiffres sur la taille et la croissance du marché ?
  • Quels leviers tirent la croissance du marché et leur évolution ?
  • Quel est le positionnement des entreprises sur la chaine de valeur ?
  • Comment se différencient les entreprises du marché ?
  • Données issues de plusieurs dizaines de bases de données

Pack 5 études (-15%) France

75.6 € HT / étude
378 € au lieu de 445 € HT -15%
  • 5 études au prix de 75,6€HT par étude à choisir parmi nos 800 titres sur le catalogue France pendant 12 mois
  • Conservez -15% sur les études supplémentaires achetées
  • Choisissez le remboursement des crédits non consommés au terme des 12 mois (durée du pack)

Consultez les conditions du pack et de remboursement des crédits non consommés.

Ajouts et mises à jour

  • 03/03/2024 - Mise à jour des données financières de l'entreprise Puressentiel France
  • 02/01/2024 - Mise à jour des données financières de l'entreprise Pranarôm (Inula Groupe)
  • 02/12/2023 - Mise à jour des données financières de l'entreprise Puressentiel France
  • 29/11/2023 - Ajout des informations de l'entreprise Atlantique Nature
  • 01/10/2023 - Mise à jour des données financières de l'entreprise Pranarôm (Inula Groupe)
  • 20/08/2023 - Mise à jour des données financières de l'entreprise Puressentiel France
  • 06/07/2023 - Ajout des informations de l'entreprise Institut Endobiogénie
  • 06/07/2023 - Ajout des informations de l'entreprise Herbalife
  • 06/07/2023 - Ajout des informations de l'entreprise Densmore
  • 04/06/2023 - Mise à jour des données financières de l'entreprise Pranarôm (Inula Groupe)
  • 28/05/2023 - Ajout des informations de l'entreprise Olisma
  • 19/05/2023 - Mise à jour des données financières de l'entreprise Puressentiel France
  • 21/02/2023 - Mise à jour des données financières de l'entreprise Ipsen
  • 18/02/2023 - Mise à jour des données financières de l'entreprise Puressentiel France

Nos références clients

Ils ont consulté nos études Découvrir les avis (+500)

Malcolm Vincent
Linkedin logo

Malcolm Vincent

Astoria Finance

Gregoire de Castelnau
Linkedin logo

Gregoire de Castelnau

Stags Participations

Timothé Huignard
Linkedin logo

Timothé Huignard

PWC

Paul-Alexis Kebabtchieff
Linkedin logo

Paul-Alexis Kebabtchieff

BCG

Aymeric Granet
Linkedin logo

Aymeric Granet

Publicis Consultant

interviews & Cas clients Toutes les interviews et cas clients (45)

La pépite Interview

BFM Business

Paul-Alexis Kebabtchieff

Boston Consulting Group

Marie Guibart

Kea Partners

Elaine, Durand

Crédit Agricole, Information & Veille

Philippe Dilasser

Initiative & Finance

Anne Baudry

Metro

Amaury Wernert

Kroll (Duff & Phelps)

Smart Leaders Interview

B-Smart

Une question ?
Notre équipe est à votre écoute au   (+33) 9 70 46 55 00